News

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...
The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...
Thoughtful discussion on the unmet clinical needs in treating abdominal aortic aneurysms and approaches to creating future ...
Busby's and Hutchison's attorneys argue that Busby paid for this home design work to Hutchison's business AL&H Custom Homes. FBI special agent Brannon Coker previously testified that Hutchison ...
BA (Hons) Design for Art Direction will develop the practical, conceptual and leadership skills you’ll need for a career in art direction and creative production. The course emphasises collaboration ...
Urquiola is one of 25 artists, designers and architects commissioned by Loewe for Milan Design Week 2025, which sees the cross-cultural and ritualistic nature of tea considered by designers including ...
This initiative is part of ARIA’s Safeguarded AI programme. The project, known as ‘Transforming clinical trial design using safe and reliable AI,’ will be a collaborative effort between Lindus Health ...
"By integrating NetraMark's technology into our clinical trial design, we can identify the patients most likely to drive positive trial outcomes, leading to fewer required patients per trial ...
Under this agreement, NetraMark's AI technology will initially be used for Phase 2 (neuroscience and oncology clinical trials) and select Phase 3 clinical trials conducted by Worldwide ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
hThe Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA iDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, ...
In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone ...